GRANDE PHARMACIE DE LA CROIX BLEUE : revenue, balance sheet and financial ratios

GRANDE PHARMACIE DE LA CROIX BLEUE is a French company founded 22 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in NIMES (30000), this company of category PME shows in 2022 a revenue of 1.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - GRANDE PHARMACIE DE LA CROIX BLEUE (SIREN 452095508)
Indicator 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue N/C 1 700 792 € N/C N/C N/C N/C N/C N/C 4 418 113 € 3 966 791 € 3 282 584 €
Net income -110 274 € -37 233 € -14 164 € -23 971 € 49 093 € 142 594 € 242 668 € 236 224 € 190 125 € 180 013 € 171 604 €
EBITDA N/C -11 497 € N/C N/C N/C N/C N/C N/C 315 452 € 324 074 € 313 443 €
Net margin N/C -2.2% N/C N/C N/C N/C N/C N/C 4.3% 4.5% 5.2%

Revenue and income statement

In 2023, GRANDE PHARMACIE DE LA CROIX BLEUE records a net loss of 110 k€. This deficit will reduce equity on the balance sheet.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-110 274 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 99%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 44%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

98.553%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

43.829%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

18.5%

Solvency indicators evolution
GRANDE PHARMACIE DE LA CROIX BLEUE

Sector positioning

Debt ratio
98.55 2023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average +6 pts over 3 years

In 2023, the debt ratio of GRANDE PHARMACIE DE LA CR... (98.55) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
43.83% 2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average -9 pts over 3 years

In 2023, the financial autonomy of GRANDE PHARMACIE DE LA CR... (43.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
-44.68 years 2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent

In 2022, the repayment capacity of GRANDE PHARMACIE DE LA CR... (-44.68) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 131.34. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

131.344

Liquidity indicators evolution
GRANDE PHARMACIE DE LA CROIX BLEUE

Sector positioning

Liquidity ratio
131.34 2023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Watch -28 pts over 3 years

In 2023, the liquidity ratio of GRANDE PHARMACIE DE LA CR... (131.34) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
-0.84x 2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average

In 2022, the interest coverage of GRANDE PHARMACIE DE LA CR... (-0.8x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
GRANDE PHARMACIE DE LA CROIX BLEUE

Positioning of GRANDE PHARMACIE DE LA CROIX BLEUE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare GRANDE PHARMACIE DE LA CROIX BLEUE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about GRANDE PHARMACIE DE LA CROIX BLEUE

What is the revenue of GRANDE PHARMACIE DE LA CROIX BLEUE ?

The revenue of GRANDE PHARMACIE DE LA CROIX BLEUE in 2022 is 1.7 M€.

Is GRANDE PHARMACIE DE LA CROIX BLEUE profitable?

GRANDE PHARMACIE DE LA CROIX BLEUE recorded a net loss in 2023.

Where is the headquarters of GRANDE PHARMACIE DE LA CROIX BLEUE ?

The headquarters of GRANDE PHARMACIE DE LA CROIX BLEUE is located in NIMES (30000), in the department Gard.

Where to find the tax return of GRANDE PHARMACIE DE LA CROIX BLEUE ?

The tax return of GRANDE PHARMACIE DE LA CROIX BLEUE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GRANDE PHARMACIE DE LA CROIX BLEUE operate?

GRANDE PHARMACIE DE LA CROIX BLEUE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.